Old Lyme, CT, United States of America

Keith McCarthy, Legal Representative

This inventor holds 1 USPTO granted patent. Top assignee: Roche Palo Alto LLC. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith McCarthy, Legal Representative. Retrieved from https://idiyas.com/inventor/keith-mccarthy-legal-representative

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Keith McCarthy

Introduction: Keith McCarthy, a legal representative based in Old Lyme, CT (US), has made a notable mark in the field of pharmaceuticals with his groundbreaking invention.

Latest Patents: McCarthy holds one patent for "Polymorphic antiviral nucleoside compounds", which focuses on the polymorphic crystalline hydrochloride salts of a nucleoside valinate ester, specifically designed to treat diseases mediated by the Hepatitis C Virus.

Career Highlights: Currently working at Roche Palo Alto LLC, McCarthy's expertise and dedication have significantly contributed to the advancement of antiviral medications. His meticulous approach to research and development has led to the creation of innovative solutions in the pharmaceutical industry.

Collaborations: Throughout his career, McCarthy has collaborated closely with talented individuals in the field. One of his esteemed coworkers is Kondamraj Birudaraj, with whom he has worked closely on various projects aimed at combating infectious diseases.

Conclusion: Inventor Keith McCarthy's passion for innovation and his commitment to improving healthcare through his inventions serve as a testament to his remarkable contributions to the field of pharmaceuticals. His patent represents a significant milestone in the journey towards finding effective treatments for diseases such as Hepatitis C.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…